Morgan D, Freshney R I, Darling J L, Thomas D G, Celik F
Br J Cancer. 1983 Feb;47(2):205-14. doi: 10.1038/bjc.1983.28.
A method has been developed for measuring the drug sensitivity of human gliomas in short-term culture, using scintillation counting or autofluorography. Cell cultures prepared from malignant astrocytomas were treated with anticancer drugs whilst in exponential growth in microtitration plates. After drug treatment and a recovery period, residual viability was measured by [3H] leucine incorporation followed by scintillation counting or by [35S] methionine incorporation and autofluorography in situ. In 5 glioma cell lines tested against 6 drugs, the microtitration method correlated well with monolayer cloning. Although replicate samples of the same tumour showed little variation in chemosensitivity, there was marked variation between the chemosensitivities of cultures derived from the tumours of different patients. However, as variability between replicates was apparent during drug exposure or shortly after, it is important to allow the assay to run as long as possible after drug removal. It is hoped that this assay may provide the basis of a method for the prediction of in vivo chemosensitivity or the screening of potential chemotherapeutic drugs.
已开发出一种利用闪烁计数法或自动放射自显影术来测定短期培养的人胶质瘤药物敏感性的方法。从恶性星形细胞瘤制备的细胞培养物在微量滴定板中呈指数生长时用抗癌药物进行处理。药物处理及恢复期后,通过[3H]亮氨酸掺入后进行闪烁计数或通过[35S]甲硫氨酸掺入及原位自动放射自显影术来测定残余活力。在针对6种药物测试的5种胶质瘤细胞系中,微量滴定法与单层克隆法相关性良好。尽管同一肿瘤的重复样本在化学敏感性方面变化很小,但来自不同患者肿瘤的培养物在化学敏感性上存在显著差异。然而,由于在药物暴露期间或之后不久重复样本之间就明显存在变异性,所以在药物去除后让测定尽可能长时间进行很重要。希望这种测定方法可为预测体内化学敏感性或筛选潜在化疗药物的方法提供基础。